Pulmonary Biobank Consortium

The Pulmonary Biobank Consortium (PBC) is a transversal, public and non-profit structure, promoted by the CIBER of Respiratory Diseases, where hospitals participate voluntary providing samples and relevant clinical information obtained from patients who come for care reasons (number B.0000471 National Registry of Biobanks - ISCIII). PBC was created in 2008 and its activity has been certified by the ISO9001:2015 standard (formerly ISO9001:2008) since 2012.

PBC coordinate different hospitals to:

- Cover the needs of researchers in terms of biological samples.

- Ensure the pre-analytical control of the samples to minimize artifacts and variations between batches of samples.

- Collaborate and participate in similar cooperative structures.

Its mission is to provide quality samples and data to national and international researchers, to promote reproducible translational biomedical research, and thus improve diagnosis and development of new treatments.

Also participates in:

- The ISCIII Biobanks and Biomodels Platform (https://www.isciiibiobanksbiomodels.es/)

- The PREDICTIVE MEDICINE Program of the Precision Medicine Infrastructure associated with Science and Technology (IMPaCT) https://www.isciii.es/QueHacemos/Financiacion/IMPaCT/Paginas/default.aspx

- Coordination and management of samples in national multicenter projects:

• Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC project).
• Spanish registry of patients with sleep apnea and daytime sleepiness (HYPNOSA project).
• Impact of Sleep-disordered Breathing Management in Systemic Hypertension Control (METASLEEP project).
  
  

For more information click on the following link:

https://biobancopulmonar.ciberes.org/en

Organisation chart

                                               

Cooperative Groups

                           

Services available

• Supply of: 
• Tissue and haemoderivative samples with strict quality criteria.
• Standardised clinical data established by consensus.
• DICOM Images (Computerised Tomography).
• Centralized storage of sample collections.
• Management of national and international shipments.
• Setting up new collections in multi-centre studies.
• Control, monitoring and audits multi-center collections.
• On-line platform for registration of standardized data.
• Establishing quality management systems.
• Support on ethical-legal aspects.
• Scientific-technical advice for  use and creation new collections.
• Support formanagement and creation of biobanks.